Re-weighting the model for end-stage liver disease score components.
about
Organ allocation for chronic liver disease: model for end-stage liver disease and beyondPredictive factors of short term outcome after liver transplantation: A reviewModel for End-stage Liver DiseaseComparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting listPrognostic performance of a series of model for end-stage liver disease and respective Δ scores in patients with hepatitis B acute-on-chronic liver failure.Survival benefit-based deceased-donor liver allocationSarcopenia and mortality after liver transplantation.Predicting clinical outcomes using baseline and follow-up laboratory data from the hepatitis C long-term treatment against cirrhosis trial.Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list.Role of MELD score and serum creatinine as prognostic tools for the development of acute kidney injury after liver transplantation.Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumorsCurrent trends in living donor liver transplantation for primary sclerosing cholangitis.Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era.Impact of MELD-based allocation on end-stage renal disease after liver transplantation.Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis.Difference between CKD-EPI and MDRD equations in calculating glomerular filtration rate in patients with cirrhosis.Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver diseaseEffect of pretransplant serum creatinine on the survival benefit of liver transplantation.A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantation.Chronic Kidney Disease and Related Long-Term Complications After Liver Transplantation.Liver volume in the cirrhotic patient: does size matter?Impact of MELD Allocation System on Waiting List and Early Post-Liver Transplant Mortality.Prognostic Abilities and Quality Assessment of Models for the Prediction of 90-Day Mortality in Liver Transplant Waiting List PatientsPropensity score-based survival benefit of simultaneous liver-kidney transplant over liver transplant alone for recipients with pretransplant renal dysfunction.Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score?Model for end-stage liver disease: end of the first decade.Kidney, pancreas and liver allocation and distribution in the United StatesA comprehensive validation of HBV-related acute-on-chronic liver failure models to assist decision-making in targeted therapeuticsPatient-specific prediction of ESRD after liver transplantation.Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry.A review of utility-based allocation strategies to maximize graft years of deceased donor kidneys.Evidence-based development of liver allocation: a review.Long-term outcome after liver transplantation.Financial Impact of Liver Sharing and Organ Procurement Organizations' Experience With Share 35: Implications for National Broader Sharing.Model for end-stage liver disease score and MELD exceptions: 15 years later.Sarcopenia in Patients with Chronic Liver Disease: Can It Be Altered by Diet and Exercise?Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis.Variant outcomes of liver transplantation for hepatitis C virus patients in different age categories: impact of the model for end-stage liver disease score.Pretransplant renal function according to CKD-EPI cystatin C equation is a prognostic factor of death after liver transplantation.Severe muscle depletion predicts postoperative length of stay but is not associated with survival after liver transplantation.
P2860
Q24633350-414904F2-3B8C-4BE8-80CE-E984929EF53CQ26741225-11EE8BBE-4AA2-4446-BEA7-4F3528F5F71FQ26864971-4B1EC0B8-7D7E-4157-ABCE-E7DD965D3782Q28731277-45920AA5-EBCA-4F28-B02C-E7EAA68D43ABQ33608736-E9B16A61-91B7-4BEF-A1EA-21D14AE4BC1CQ33956711-1CD09586-5089-4477-BB39-3BE5CE2130F1Q34037794-BD723BCF-89BF-403D-A766-9D7A5D6DAE9AQ34064042-D5118057-8B25-4DE1-9645-6F899C187DA3Q34562058-BECC5C32-6D72-4DDD-8FB7-74F3AB4E3292Q34745144-255B5F07-27C7-4099-8DF4-578DA3B3C7F9Q35096126-1C674BD3-2B3B-4BBB-8776-87AD9C222301Q35162784-8E7D2FDA-D1AB-48F1-B5A7-7D4FC364859FQ35464017-0D8883F0-A0C2-4A45-ADA7-72402E8DC42DQ35465299-5C4A460E-6030-4A91-A9EF-3A79608E7416Q35539213-BBE395BB-D807-484A-9259-E1C2966F858BQ35555707-E5563B3F-9C33-4433-8EA5-1C621D5235E1Q35651549-CDDEB405-D1EE-4DD2-A93C-A0F055BD204DQ35974621-D05B6172-5447-45B8-BDDE-042FA472FEF4Q35988340-44A9C427-8A27-447B-9AF7-3EA00C2FF6F6Q36015474-903F44D4-1731-4804-AFD3-AA84CA2602B6Q36047321-BECCEC49-E6AE-4893-8B1E-19FACD864251Q36051596-9EFBDA08-0706-4960-8817-76DCCFDE7BD0Q36262430-9C0F9E67-F879-4BA9-8FF8-189FD339B4D2Q36359806-EB102C09-6E9E-4BF4-BC40-BEA4EE064720Q36507944-55E4FB74-37E1-43DF-857A-B77BD5BBA46DQ36588122-2F17B116-DA26-4DA1-B425-AD59B0584C32Q36591435-1939DCB6-711D-477D-AAF6-A6F8325DA358Q37261136-6644DE66-80E1-402D-8967-4BCF6184FE82Q37340234-14C5A2BA-CF5E-4B80-B586-AE5EFFEFCF44Q37638019-D97B8D39-4A0C-4E93-B0C6-D4764302E92AQ37832286-0264B154-1BF2-42E0-A3A5-E787C9BEB52BQ37880205-756E345A-3F10-437F-A789-A21A676ADF72Q38002368-74645E8D-F04E-496B-9290-DEBCB8A27EB1Q38386767-46497CF5-2040-47E6-AD7B-2D2E8A027892Q38504284-6E38514A-1789-40B3-AD66-C1EB783D78B5Q38884255-C0B07D19-55D1-4FAA-A16E-5CEFD98E2479Q39452131-5B9C8F7E-2E2E-4C84-B3D0-46CDC0B9B34CQ40363980-76E211A1-F4E7-4B49-A834-5C3E06CA5A92Q41185552-38D51700-0253-4385-AD66-99B584F209A6Q42228448-9A33CFA7-CBB1-4566-AE60-97B37BB2D7E3
P2860
Re-weighting the model for end-stage liver disease score components.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Re-weighting the model for end-stage liver disease score components.
@en
Re-weighting the model for end-stage liver disease score components.
@nl
type
label
Re-weighting the model for end-stage liver disease score components.
@en
Re-weighting the model for end-stage liver disease score components.
@nl
prefLabel
Re-weighting the model for end-stage liver disease score components.
@en
Re-weighting the model for end-stage liver disease score components.
@nl
P2093
P1433
P1476
Re-weighting the model for end-stage liver disease score components.
@en
P2093
Anna S F Lok
Camelia S Sima
Douglas E Schaubel
Pratima Sharma
Robert M Merion
P304
P356
10.1053/J.GASTRO.2008.08.004
P407
P577
2008-08-15T00:00:00Z